LSE:GHG

Stock Analysis Report

Executive Summary

Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia.


Snowflake Analysis

Very undervalued with solid track record.


Similar Companies

Share Price & News

How has Georgia Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: GHG's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

23.1%

GHG

4.1%

GB Consumer Retailing

8.6%

GB Market


1 Year Return

-52.4%

GHG

-7.6%

GB Consumer Retailing

-19.4%

GB Market

Return vs Industry: GHG underperformed the UK Consumer Retailing industry which returned -9% over the past year.

Return vs Market: GHG underperformed the UK Market which returned -21.5% over the past year.


Shareholder returns

GHGIndustryMarket
7 Day23.1%4.1%8.6%
30 Day2.6%0.7%-3.5%
90 Day-15.7%-9.5%-23.0%
1 Year-52.1%-52.4%-4.0%-7.6%-15.5%-19.4%
3 Year-72.2%-72.4%5.9%-1.9%-8.8%-19.9%
5 Yearn/a0.9%-8.3%4.2%-19.0%

Price Volatility Vs. Market

How volatile is Georgia Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Georgia Healthcare Group undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GHG (£0.97) is trading below our estimate of fair value (£6.84)

Significantly Below Fair Value: GHG is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GHG is good value based on its PE Ratio (10.7x) compared to the Consumer Retailing industry average (16.2x).

PE vs Market: GHG is good value based on its PE Ratio (10.7x) compared to the UK market (13.3x).


Price to Earnings Growth Ratio

PEG Ratio: GHG is good value based on its PEG Ratio (0.5x)


Price to Book Ratio

PB vs Industry: GHG is good value based on its PB Ratio (0.9x) compared to the GB Consumer Retailing industry average (1.1x).


Next Steps

Future Growth

How is Georgia Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

24.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GHG's forecast earnings growth (22.2% per year) is above the savings rate (0.5%).

Earnings vs Market: GHG's earnings (22.2% per year) are forecast to grow faster than the UK market (15.4% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GHG's revenue (7.8% per year) is forecast to grow faster than the UK market (2.5% per year).

High Growth Revenue: GHG's revenue (7.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GHG's Return on Equity is forecast to be low in 3 years time (17.4%).


Next Steps

Past Performance

How has Georgia Healthcare Group performed over the past 5 years?

11.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GHG has high quality earnings.

Growing Profit Margin: GHG's current net profit margins (4.8%) are higher than last year (4.1%).


Past Earnings Growth Analysis

Earnings Trend: GHG's earnings have grown by 12.2% per year over the past 5 years.

Accelerating Growth: GHG's earnings growth over the past year (33.6%) exceeds its 5-year average (12.2% per year).

Earnings vs Industry: GHG earnings growth over the past year (33.6%) exceeded the Consumer Retailing industry 29.8%.


Return on Equity

High ROE: GHG's Return on Equity (11.5%) is considered low.


Next Steps

Financial Health

How is Georgia Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: GHG's short term assets (GEL393.4M) exceed its short term liabilities (GEL154.2M).

Long Term Liabilities: GHG's short term assets (GEL393.4M) do not cover its long term liabilities (GEL594.7M).


Debt to Equity History and Analysis

Debt Level: GHG's debt to equity ratio (45.4%) is considered high.

Reducing Debt: GHG's debt to equity ratio has reduced from 94% to 45.4% over the past 5 years.

Debt Coverage: GHG's debt is well covered by operating cash flow (45.8%).

Interest Coverage: GHG's interest payments on its debt are not well covered by EBIT (2.1x coverage).


Balance Sheet


Next Steps

Dividend

What is Georgia Healthcare Group's current dividend yield, its reliability and sustainability?

3.57%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: GHG's dividend (2%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (2.49%).

High Dividend: GHG's dividend (2%) is low compared to the top 25% of dividend payers in the UK market (6.84%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether GHG's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if GHG's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (21.4%), GHG's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GHG's dividends in 3 years are forecast to be well covered by earnings (21.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average management tenure


CEO

Nick Gamkrelidze (39yo)

4.67s

Tenure

GEL1,024,388

Compensation

Mr. Nikoloz Gamkrelidze, also known as Nick, has been the Chief Executive Officer of Georgia Healthcare Group PLC since august 8, 2015. Mr. Gamkrelidze served as Group Chief Financial Officer and Deputy Ch ...


CEO Compensation Analysis

Compensation vs Market: Nick's total compensation ($USD1.02M) is above average for companies of similar size in the UK market ($USD752.66K).

Compensation vs Earnings: Nick's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Nikoloz Gamkrelidze
CEO & Executive Director4.67yrsGEL1.02m0.29% GEL368.4k
Irakli Gogia
Deputy CEO of Finance & Operations3.08yrsGEL371.49k0.10% GEL129.4k
Ketevan Kalandarishvili
Head of Investor Relationsno datano datano data
Nino Kortua
Chief Legal Officer5yrsno datano data
Enrico Beridze
Head of Business Development & Strategic Marketingno datano datano data
Medea Chkhaidze
Chief Human Resource Officer5yrsno datano data
David Vakhtangishvili
Deputy CEO of Risks & IT3.08yrsGEL370.97kno data
Gregory Khurtsidze
Deputy Chief Executive Officer of Clinical4.17yrsno datano data
Giorgi Mindiashvili
Chief Operating Officer of Hospitals5.08yrsGEL376.46k0.081% GEL103.7k
Manana Khurtsilava
Head of Internal Audit5yrsno datano data

4.8yrs

Average Tenure

Experienced Management: GHG's management team is considered experienced (4.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Nikoloz Gamkrelidze
CEO & Executive Director4.67yrsGEL1.02m0.29% GEL368.4k
Tim Elsigood
Independent Non-Executive Director4.58yrsGEL136.07kno data
Irakli Gilauri
Non-Executive Directorno datano data0.18% GEL230.4k
Jacques Richier
Independent Non-Executive Director4.58yrsGEL107.00kno data
David Morrison
Senior Independent Non-Executive Director4.58yrsGEL156.00kno data
Ingeborg Øie
Independent Non-Executive Director4.58yrsGEL120.95kno data
Mike Anderson
Independent Non-Executive Director4.58yrsGEL107.00kno data
William Huyett
Independent Chairman of the Board1.58yrsGEL119.99kno data
Fabian Stephan Blank
Independent Non-Executive Director1.58yrsGEL60.67kno data

4.6yrs

Average Tenure

63yo

Average Age

Experienced Board: GHG's board of directors are considered experienced (4.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: GHG insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Georgia Healthcare Group PLC's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Georgia Healthcare Group PLC
  • Ticker: GHG
  • Exchange: LSE
  • Founded: 2015
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: UK£128.719m
  • Shares outstanding: 129.37m
  • Website: https://www.ghg.com.ge

Number of Employees


Location

  • Georgia Healthcare Group PLC
  • 84 Brook Street
  • London
  • Greater London
  • W1K 5EH
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GHGLSE (London Stock Exchange)YesCommon SharesGBGBPNov 2015
GHGLBATS-CHIXE (BATS 'Chi-X Europe')YesCommon SharesGBGBPNov 2015
1EBBST (Boerse-Stuttgart)YesCommon SharesDEEURNov 2015

Biography

Georgia Healthcare Group PLC, together with its subsidiaries, provides healthcare services in Georgia. It operates through Healthcare Services, Pharmacy and Distribution, and Medical Insurance segments. The company operates 16 referral hospitals with a total of 2,825 beds that offer secondary and tertiary level healthcare services; 21 community hospitals, including 495 beds providing basic outpatient and inpatient healthcare services; and 270 pharmacies under the GPC and Pharmadepot brand names. It also operates 16 polyclinics, day-clinics, and 8 dental clinics that offer outpatient diagnostic and treatment services; provides a range of medical insurance products, such as personal accident, term life, and medical and travel insurance policies to corporate and retail clients; and medicines, as well as Para pharmacy products. The company was founded in 2015 and is headquartered in London, the United Kingdom. Georgia Healthcare Group PLC operates as a subsidiary of Georgia Capital PLC. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/09 23:38
End of Day Share Price2020/04/09 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.